Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemiaOTTMANN, Oliver G; BUG, Gesine; KRAUTER, Jürgen et al.Seminars in hematology. 2007, Vol 44, Num 3, pp 183-192, issn 0037-1963, 10 p.Article

Unstimulated leukapheresis in patients and donors: comparison of two apheresis systemsSCHULZ, Miriam; BIALLECK, Heike; THORAUSCH, Kristin et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 6, pp 1622-1629, issn 0041-1132, 8 p.Article

Chimaerism and erythroid marker expression after microinjection of human acute myeloid leukaemia cells into murine blastocystsDÜRR, Michael; HARDER, Friedrich; MERKEL, Angela et al.Oncogene (Basingstoke). 2003, Vol 22, Num 57, pp 9185-9191, issn 0950-9232, 7 p.Article

Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatinKLEIN, Stefan A; BUG, Gesine; MOUSSET, Sabine et al.British journal of haematology. 2011, Vol 154, Num 1, pp 143-146, issn 0007-1048, 4 p.Article

Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemiaBUG, Gesine; SCHWARZ, Kerstin; SCHOCH, Claudia et al.Haematologica (Roma). 2007, Vol 92, Num 4, pp 542-545, issn 0390-6078, 4 p.Article

Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosisBUG, Gesine; ANARGYROU, Konstantinos; TONN, Torsten et al.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 10, pp 1843-1850, issn 0041-1132, 8 p.Article

Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARα-positive leukemic stem cellsXIAOMIN ZHENG; SESHIRE, Anita; RÜSTER, Brigitte et al.Haematologica (Roma). 2007, Vol 92, Num 3, pp 323-331, issn 0390-6078, 9 p.Article

Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34⁺ cell expansion and maturationKOSCHMIEDER, Steffen; BUG, Gesine; SCHRÖDER, Bernd et al.International journal of hematology. 2001, Vol 73, Num 1, pp 71-77, issn 0925-5710Article

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisTHOL, Felicitas; WEISSINGER, Eva M; HOFMANN, Wolf-Karsten et al.Haematologica (Roma). 2010, Vol 95, Num 10, pp 1668-1674, issn 0390-6078, 7 p.Article

Monitoring of donor chimerism in sorted CD34⁺ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationBORNHÄUSER, Martin; OELSCHLAEGEL, Uta; THEUSER, Catrin et al.Haematologica (Roma). 2009, Vol 94, Num 11, pp 1613-1617, issn 0390-6078, 5 p.Article

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemiaBUG, Gesine; BITTER, Markus; NEUBAUER, Andreas et al.Cancer. 2005, Vol 104, Num 12, pp 2717-2725, issn 0008-543X, 9 p.Article

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and ―5/5q―MIDDEKE, Jan M; BEELEN, Dietrich; SCHWERDTFEGER, Rainer et al.Blood. 2012, Vol 120, Num 12, pp 2521-2528, issn 0006-4971, 8 p.Article

Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemiaROMANSKI, Annette; BACIC, Biserka; BUG, Gesine et al.Haematologica (Roma). 2004, Vol 89, Num 4, pp 419-426, issn 0390-6078, 8 p.Article

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromesTHOL, Felicitas; KADE, Sofia; GÖHRING, Gudrun et al.Blood. 2012, Vol 119, Num 15, pp 3578-3584, issn 0006-4971, 7 p.Article

Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3⁺CD4⁺-ratio in severe GvHD or relapseBREMM, Melanie; HUENECKE, Sabine; BADER, Peter et al.Journal of immunological methods. 2011, Vol 373, Num 1-2, pp 36-44, issn 0022-1759, 9 p.Article

Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic SyndromesTHOL, Felicitas; FRIESEN, Inna; GÖHRING, Gudrun et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2499-2506, issn 0732-183X, 8 p.Article

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantationSCHMID, Christoph; SCHLEUNING, Michael; KEIL, Felix et al.Blood. 2006, Vol 108, Num 3, pp 1092-1099, issn 0006-4971, 8 p.Article

A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemiaMÜLLER-TIDOW, Carsten; BUG, Gesine; MUNZERT, Gerd et al.British journal of haematology. 2013, Vol 163, Num 2, pp 214-222, issn 0007-1048, 9 p.Article

Early molecular response to posttransplantation imatinib determines outcome in MRD⁺ philadelphia-positive acute lymphoblastic leukemia (Ph⁺ ALL)WASSMANN, Barbara; PFEIFER, Heike; PERZ, Jolanta et al.Blood. 2005, Vol 106, Num 2, pp 458-463, issn 0006-4971, 6 p.Article

Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cellsBUG, Gesine; GÜL, Hilal; RUTHARDT, Martin et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2537-2541, issn 0008-5472, 5 p.Article